SDHAF2 and cancer: SDHAF2—early onset of disease and high risk of multifocal, some patients were asymptomatic, tumors were detected through family coverage, early onset—diagnosis at an average age of 33.Patients inheriting mutation from mother, do not have PGL disease (“cancer free carriers”)